News & Updates

An emulation of a randomized target trial suggests that molnupiravir may reduce hospital admission or death in adults who have tested positive for COVID-19 during the predominance of Omicron who were at high risk of progression to severe disease.

In Singapore, diagnostic radiographers were able to cope with the high demands of the COVID-19 pandemic in terms of provision of information, supplies, and physical equipment, a survey shows. However, they were less prepared to manage human factors, such as mental health and staff morale.

Liver outcomes do not differ between types 1 and 2 autoimmune hepatitis presenting in childhood, reports a recent study.

Use of a single dose of a new bioadhesive 2% clindamycin vaginal gel in the treatment of bacterial vaginosis appears to result in a rapid resolution of symptoms, with high acceptability among women, as reported in a study.

Researchers from the Chinese University of Hong Kong (CUHK) have developed an automatic retinal image analysis (ARIA) technology that utilizes machine learning to improve cardiovascular disease (CVD) risk estimates in people living with HIV (PLWH) who have cardiovascular (CV) risk factors.

The bivalent mRNA-1273.214 booster vaccine provides superior immunogenicity compared with the original COVID-19 mRNA-1273 vaccine in a phase III study, according to an expert who presented at ECCMID 2023.

SARS-CoV-2 infection puts individuals at increased risk of developing diabetes, contributing to between 3 percent and 5 percent excess burden of diabetes at a population level, as reported in a study.